Navigation Links
Metformin Won't Aid Breast Cancer Survival in Diabetics
Date:5/14/2013

TUESDAY, May 14 (HealthDay News) -- Despite prior research suggesting that the widely used diabetes drug metformin might help cancer patients, a new study finds it does not boost survival for older breast cancer patients with diabetes.

Previous research has found that metformin was associated with an up to 30 percent reduction in new cancers in breast cancer patients without diabetes, noted study author Dr. Iliana Lega, a research fellow at Women's College Hospital in Toronto. Prior research has also tied use of the drug to slowed tumor growth.

"Metformin is a drug commonly used by diabetic patients to control the amount of glucose [sugar] in their blood," Lega explained in a hospital news release. "Although existing scientific literature suggests that the drug may prevent new cancers and death from breast cancer, our study found the drug did not significantly impact survival rates in our patients."

The study included more than 2,300 women, aged 66 and older, with diabetes who took metformin and were diagnosed with breast cancer between 1997 and 2008. The women were followed from the time of their diagnosis until their death or until early 2010.

Metformin use was not associated with any significant drop in breast cancer deaths, according to the study published online recently in the journal Diabetes Care.

"What makes our study so unique is that while the effects of metformin have been well documented, previous research has not examined the cumulative effects of the drug on patients, particularly breast cancer patients with diabetes," Lega said. "This is important given that diabetic patients may switch drugs over the course of their treatment."

She and her colleagues said further research is necessary in younger patients who have both breast cancer and diabetes.

"Understanding the effects of metformin on breast cancer patients is critical in helping address the gap in cancer outcomes in pat
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Added benefit of saxagliptin/metformin combination is not proven
2. Metformin improves blood glucose levels and BMI in very obese children
3. Study: Metformin offers cardio benefits over sulfonylureas in diabetes
4. Metformin may lower cancer risk in people with Type 2 diabetes
5. Metformin Outperforms Common Class of Diabetes Drugs in Study
6. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
7. Cognitive training improves executive function in breast cancer survivors
8. A Little Formula Might Help Breast-Feeding for Some Babies
9. Socializing May Ease Pain of Breast Cancer
10. Fun and friends help ease the pain of breast cancer
11. Just How Might Exercise Lower Breast Cancer Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Metformin Won't Aid Breast Cancer Survival in Diabetics
(Date:4/24/2014)... Oregon State University researcher has found a relationship between ... of autism spectrum disorder in very young children. ... to show a direct relationship between motor skills and ... motor skills should be included in treatment plans for ... professor in OSU,s College of Public Health and Human ...
(Date:4/24/2014)... New research led by a scientist at the University ... key element in the development of the nervous system ... of breast cancer., A research team, led by ... the Department of Biology at York, has studied how ... tumours. These channels are found in the membranes of ...
(Date:4/23/2014)... Pregnant immigrants from Sub-Saharan Africa, Latin America ... pregnancy, according to new research from St. Michael,s ... British Journal of Obstetrics and Gynaecology , ... among immigrants and native-born women in six high-immigration ... Spain (Catalonia and Valencia) and the United States ...
(Date:4/23/2014)... at the National Institute of Arthritis and Musculoskeletal and ... of the Ross Prize in Molecular Medicine, conferred by ... . The award will be given on June 9 ... followed by scientific presentations by Dr. O,Shea and other ... of Health. , The award, which includes a $50,000 ...
(Date:4/23/2014)... that rats exposed to high-energy particles, simulating conditions astronauts ... lapses in attention and slower reaction times, even when ... , The cognitive impairments which affected a large ... appear to be linked to protein changes in the ... hold true in humans, suggest it may be possible ...
Breaking Medicine News(10 mins):Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Breast cancer replicates brain development process 2Health News:Pregnancy complications may be more common in immigrants from certain regions 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3
... international body of knowledge to Texas,research center in ... The University of,North Texas Health Science Center ... recently added several new members to its faculty,to ... and,osteopathic manipulative medicine., Anuja Ghorpade has joined ...
... WALTHAM, Mass., Nov. 21 Inverness Medical,Innovations, Inc. (Amex: ... announced public offering on Tuesday. The Company sold a ... offering price of $61.49,per share. The total number of ... the underwriters upon their exercise of their,over-allotment option in ...
... 30,000 Clinic Locations, WASHINGTON, Nov. 21 ... announced the week after Thanksgiving,November 27 to December ... recommendations, influenza vaccination (flu shot) rates in young,children ... age 6 to 23,months were fully immunized for ...
... ATLANTA, Nov. 21 Eclipsys Corporation(R),(Nasdaq: ECLP ... be,participating in the Merrill Lynch Health Services Investor ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050209/FLW006LOGO ), Eclipsys ... 28th at 10:00 a.m. Eastern time. Interested parties ...
... Czymmek, as he points to the video on his computer ... fireworks flash across the screen with every pulsation of the ... there is a large release of calcium with every heartbeat. ... a major problem--perhaps even heart failure. , Czymmek has a ...
... Nov. 21 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ... Development (R&D),Day on Wednesday, November 28, 2007 at ... New York., "Amylin is focused on bringing ... our sustainable approach to the,discovery and development of ...
Cached Medicine News:Health News:UNT Health Science Center Appoints Eight New Faculty Members 2Health News:UNT Health Science Center Appoints Eight New Faculty Members 3Health News:Inverness Medical Innovations Announces Closing of Public Offering 2Health News:Asthma Foundation Offers National Flu Shot Finder 2Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 2Health News:Eclipsys to Present at the Merrill Lynch Health Services Investor Conference 3Health News:New microscope peers into secret lives of cells 2Health News:New microscope peers into secret lives of cells 3Health News:Amylin Pharmaceuticals to Present at Research & Development Day 2
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ... agreement with Hitachi Koki of Japan ... North America . NuAire will utilize its network ... and Canada to offer assistance in application ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2NuAire announces sales and service of Hitachi Koki centrifuges in North America 2
... 26, 2007 /PRNewswire-FirstCall/ --,Replidyne, Inc. today announced ... a novel topical antibiotic that has shown ... including,methicillin-resistant S. aureus (MRSA). The results of ... REP8839 appears safe,well-tolerated and associated with low ...
... in a randomized phase II/III clinical trial,anticipated ... /PRNewswire-FirstCall/ -- Cell,Therapeutics, Inc. (CTI) announced the ... with pixantrone (BBR,2778) resulted in minimal or ... significant cardiac damage.,The studies compared the cardiac ...
Cached Medicine Technology:Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 2Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 3Replidyne Announces Positive Phase I Results for Topical Antibiotic,REP8839 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: